COR
Cencora Inc.
Price performance
Sep 18, 2026About
Company activity
50 events| Time | Ticker | Type | Event | Qty | Price | Value |
|---|---|---|---|---|---|---|
| 08/14 | COR | 8-K | Dr. Lorence H. Kim Resigns from Cencora Board | — | — | — |
| 08/12 | COR | 8-K | Cencora Announces Walgreens Volume Movement and Reaffirms Fiscal 2026 Guidance | — | — | — |
| 08/05 | COR | 8-K | Cencora, Inc. Amends Multi-Currency Revolving Credit Facility | — | — | — |
| 08/05 | COR | 8-K | Cencora Reports Q3 2026 Financial Results and Raises Fiscal 2026 Guidance | — | — | — |
| 06/15 | COR | 8-K | Cencora Announces New Chief Human Resources Officer Following Retirement of Silvana Battaglia | — | — | — |
| 05/29 | COR | 8-K | Cencora Appoints Eva C. Boratto as New Chief Financial Officer | — | — | — |
| 05/06 | COR | 8-K | Cencora Reports Strong Q2 2026 Results and Raises Guidance | — | — | — |
| 03/23 | COR | 8-K | Cencora Announces Acquisition of EyeSouth Partners' Retina Business | — | — | — |
| 03/17 | COR | 8-K | Cencora Announces CFO Retirement and Reaffirms Fiscal 2026 Guidance | — | — | — |
| 03/06 | COR | 8-K | Cencora Shareholders Approve Directors and Ratify Auditor Appointment | — | — | — |
| 02/18 | COR | 8-K | Cencora Announces Merger of MWI Animal Health with Covetrus | — | — | — |
| 02/13 | COR | 8-K | Cencora Inc. Announces $3.0 Billion Senior Notes Offering | — | — | — |
| 02/11 | COR | 8-K | Cencora Prices New Senior Notes to Repay Existing Debt and Fund Operations | — | — | — |
| 02/10 | COR | 8-K | Cencora Revises Segment Reporting Structure | — | — | — |
| 02/04 | COR | 8-K | Cencora Reports Q1 2026 Results and Completes Acquisition of OneOncology | — | — | — |
| 01/22 | COR | 8-K | Cencora Appoints Ellen Cooper to Board of Directors | — | — | — |
| 01/16 | COR | 8-K | Cencora Increases Credit Facilities to Support Acquisition Financing | — | — | — |
| 12/15/25 | COR | 8-K | Cencora Announces Acquisition of OneOncology for $5B | — | — | — |
| 11/05/25 | COR | 8-K | Cencora Announces Fiscal 2025 Results and Business Reorganization | — | — | — |
| 09/09/25 | COR | 8-K | Cencora Amends Credit Facilities | — | — | — |
| 09/03/25 | COR | 8-K | Cencora Announces Agreement to Settle Stockholder Derivative Action | — | — | — |
| 08/27/25 | COR | 8-K | Cencora Appoints Mark Durcan as Chairman of the Board | — | — | — |
| 08/06/25 | COR | 8-K | Cencora Reports Strong Q3 2025 Financial Results and Raises FY 2025 Guidance | — | — | — |
| 07/03/25 | COR | 8-K | Cencora, Inc. Announces Amendment to Securitization Facility | — | — | — |
| 06/06/25 | COR | 8-K | Cencora, Inc. Amends and Restates Credit Agreement and Terminates Previous Credit Agreement | — | — | — |
| 05/28/25 | COR | 8-K | Cencora Announces Director Appointments and Resignation | — | — | — |
| 05/22/25 | COR | 8-K | Cencora, Inc. Announces Issuance of Senior Notes | — | — | — |
| 05/19/25 | COR | 8-K | Cencora, Inc. Announces Underwriting Agreement for Senior Notes Issuance | — | — | — |
| 05/07/25 | COR | 8-K | Cencora Reports Q2 2025 Results and Raises Adjusted EPS Guidance | — | — | — |
| 03/10/25 | COR | 8-K | Cencora Inc. Updates Fiscal 2025 Guidance | — | — | — |
| 03/10/25 | COR | 8-K | Cencora, Inc. Shareholders Approve All Items at 2025 Annual Meeting | — | — | — |
| 02/10/25 | COR | 8-K | Cencora Announces Share Repurchase from Walgreens Boots Alliance | — | — | — |
| 02/05/25 | COR | 8-K | Cencora Reports Q1 2025 Financial Results and Raises Guidance | — | — | — |
| 01/22/25 | COR | 8-K | Board Members Richard Gochnauer and Kathleen Hyle to Retire | — | — | — |
| 01/02/25 | COR | 8-K | Cencora Completes Acquisition of Retina Consultants of America | — | — | — |
| 12/10/24 | COR | 8-K | Cencora Closes $1.8 Billion Senior Notes Offering | — | — | — |
| 12/04/24 | COR | 8-K | Cencora Announces Pricing of Senior Notes and Underwriting Agreement | — | — | — |
| 11/27/24 | COR | 8-K | Cencora Announces $1.5 Billion Term Loan for Retina Consultants Acquisition | — | — | — |
| 11/08/24 | COR | 8-K | Cencora Announces Acquisition of Retina Consultants of America for $4.6 Billion | — | — | — |
| 11/06/24 | COR | 8-K | Cencora Announces Fiscal 2024 Results and Declares Quarterly Dividend | — | — | — |
| 10/15/24 | COR | 8-K | Cencora Inc. Amends Revolving Credit Facility and Extends Securitization Facility | — | — | — |
| 09/05/24 | COR | 8-K | Cencora Inc. Provides Fiscal 2024 Guidance and Business Developments Update | — | — | — |
| 08/16/24 | COR | 8-K | Cencora Approves New Indemnification Agreement and Updates Bylaws | — | — | — |
| 08/15/24 | COR | 8-K | Cencora Appoints Frank Clyburn to Board of Directors | — | — | — |
| 08/05/24 | COR | 8-K | Cencora Announces Share Repurchase Agreement with Walgreens | — | — | — |
| 07/31/24 | COR | 8-K | Cencora, Inc. Discloses Material Cybersecurity Incident Involving Data Exfiltration | — | — | — |
| 07/31/24 | COR | 8-K | Cencora, Inc. Reports Strong Q3 2024 Earnings and Raises Fiscal 2024 Guidance | — | — | — |
| 05/24/24 | COR | 8-K | Cencora Announces Share Repurchase from Walgreens Boots Alliance and Raises Fiscal 2024 Guidance | — | — | — |
| 05/03/24 | COR | 8-K | Gina K. Clark to Retire as Executive Vice President and Chief Communications & Administrative Officer of Cencora, Inc. | — | — | — |
| 05/01/24 | COR | 8-K | Cencora, Inc. Reports Q2 2024 Earnings, Updates Guidance, Announces Leadership Changes | — | — | — |
COR filing record
Cencora Inc. (COR): 50 8-K filings summarized, the most recent on Aug 14, 2026.
What the 8-K filings said
- Aug 14, 2026 · medium impact
On August 13, 2026, Lorence H. Kim, M.D. resigned from the Board of Directors of Cencora, Inc. effective immediately. Dr. Kim's resignation is connected to his new role as Chief Financial Officer of Commonwealth Fusion Systems, Inc., requiring additional time for his professional responsibilities. The resignation is…
Dr. Lorence H. Kim Resigns from Cencora Board - Aug 12, 2026 · medium impact
Cencora, Inc. announced that beginning July 1, 2026, certain Walgreens volume that was being serviced by the company separate from the prime vendor agreement began moving outside the company. This operational change was fully contemplated in Cencora's August 5, 2026 commentary on fourth quarter expectations for its…
Cencora Announces Walgreens Volume Movement and Reaffirms Fiscal 2026 Guidance - Aug 5, 2026 · medium impact
On July 31, 2026, Cencora, Inc. amended and restated its multi-currency senior unsecured revolving credit facility, increasing the aggregate amount of commitments from $5.5 billion to $7.0 billion and extending the maturity date to July 2031. Additionally, the company amended its receivables securitization facility…
Cencora, Inc. Amends Multi-Currency Revolving Credit Facility - Aug 5, 2026 · high impact
Cencora, Inc. reported a 5.1% year-over-year increase in revenue for the third quarter of fiscal 2026, reaching $84.8 billion. The company's GAAP diluted EPS was $3.94, while adjusted diluted EPS was $4.48. Cencora raised its fiscal 2026 adjusted diluted EPS guidance range to $17.75 to $17.95. The company also…
Cencora Reports Q3 2026 Financial Results and Raises Fiscal 2026 Guidance - Jun 15, 2026 · high impact
On June 15, 2026, Cencora, Inc. announced the retirement of Silvana Battaglia, its Executive Vice President and Chief Human Resources Officer, effective July 12, 2026. Battaglia will transition to an advisory role through the end of the year. She will be succeeded by Samantha L. Hammock, who will join Cencora as…
Cencora Announces New Chief Human Resources Officer Following Retirement of Silvana Battaglia
SEC filings in the last five years
- 82 Form 8-K
- 11 Form 10-Q
- 4 Form 10-K
- 3 Form 8-K/A